Cytocom (CBLI) Reports Q2 Loss of $0.04
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Price: $3.17 --0%
Financial Fact:
NET INCOME/(LOSS) ATTRIBUTABLE TO CLEVELAND BIOLABS, INC.: 1.14M
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
NET INCOME/(LOSS) ATTRIBUTABLE TO CLEVELAND BIOLABS, INC.: 1.14M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Cytocom (NASDAQ: CBLI) reported Q2 EPS of ($0.04).
For earnings history and earnings-related data on Cytocom (CBLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Reaction roundup: Experts, analysts weigh in on September jobs report
- Rivian reports Q3 2026 production of 19,751 vehicles
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
